Nucleic acid-based immunotherapy for chronic hepatitis B infection.

摘要

The present invention relates to the resources based immunotherapy to treat patients DNA in the mammalian case having chronic hepatitis B. This immunotherapy involves the administration of a first series of injections transcription units encoding DNA envelope antigen of hepatitis B, followed by booster injections of a transcription unit DNA encoding the envelope antigen of hepatitis B.